November 18, 2010
– Comments (9)
ALNY shares are now the second largest position in my portfolio (see this post). I think it might be a good idea to consider buying a few shares today.
Interesting...don't own any yet but I always enjoy when you suggest an "idea to buy". You must like ALNY a bit...good luck to you sir.
Alnylam Comments on Recent Roche Restructuring and Implications for RNAi Therapeutics
Tekmira shares fall as Roche to end partnership
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira
Roche Has Problems but RNA Interference Has More
a somewhat related post.
This looks to be a good find Hans!
In at 10.19...ALNY
currently in the "fund" (see here) (number of shares, ticker symbol, name, last price, break-even price).
71350 ALNY Alnylam Pharmaceuticals $9.88 $11.02,10900 ISIS Isis Pharmaceuticals $9.69 $8.27,46800 MRNA Marina Biotech $1.768 $2.10,1600 ROSG Rosetta Genomics $1.2801 $0.62,17700 RXII RXi Pharmaceuticals $3.3299 $3.21,70000 SLN:LN Silence Therapeutics $0.1374 (8.6 p) $0.0433 (2.71 p),5300 TKMR (TKM:CN) Tekmira Pharmaceuticals $5.20 $4.86.
It might be a good idea to apply this basket approach.
a few more companies to choose from (not all public companies) are here.
View World of RNAi Therapeutics in a larger map
Hello dear friend - The blog that I have written is to you especially along with a handful of others who are very special. Thank you for all that you do to make CAPS as truly special as it is!